Excess Costs Associated with Possible Misdiagnosis of Alzheimer’s Disease among Patients with Vascular Dementia in a UK CPRD Population

Manuscript Number: 

15-0685R2

Author(s): 
Mark Belger, Howard G. Birnbaum, Urvi Desai, Michael Happich, Sarah King, Noam Y. Kirson, Alan Lenox-Smith, David Price, Catherine C. Reed

Disclosures

Mark Belger

  • Equity:
    I have shares in Eli Lilly
    Sponsors:
    I am a full time employee of Eli Lilly

Howard G. Birnbaum

  • Consulting Fees:
    I am an employee of Analysis Group, Inc., an economic and healthcare consulting firm. Analysis Group received research support for this project from Eli Lilly

Urvi Desai

  • Consulting Fees:
    I am an employee of Analysis Group, Inc., an economic and healthcare consulting firm. Analysis Group received research support for this project from Eli Lilly

Michael Happich

  • Equity:
    I have Lilly stocks.
    Sponsors:
    I am employee at Eli Lilly.

Sarah King

  • Consulting Fees:
    I am an employee of Analysis Group, Inc., an economic and healthcare consulting firm. Analysis Group received research support for this project from Eli Lilly

Noam Y. Kirson

  • Consulting Fees:
    I am an employee of Analysis Group, Inc., an economic and healthcare consulting firm. Analysis Group received research support for this project from Eli Lilly.
    Grants
    • Agency: 
      Eli Lilly and Co.
      Dates: 
      2014-2015

Alan Lenox-Smith

  • Equity:
    I own some shares in Lilly
    Sponsors:
    I am a fully time employee of Lilly

David Price

  • Consulting Fees:
    Consultancy- fees paid to Research in Real Life Ltd Almirall, Amgen Inc, AstraZeneca plc, Boehringer Ingelheim, Chiesi, GlaxoSmithKline plc, Meda, Mundipharma, Napp, Novartis International AG, Pfizer, Inc. and Teva
    Equity:
    has shares in AKL Ltd which produces phytopharmaceuticals. I own 80% of Research in Real Life Ltd and its subsidiary social enterprise Optimum Patient Care
    Lecture Fees:
    Lectures/ speaking engagements- fees paid to Research in Real Life Ltd Almirall, AstraZeneca plc, Boehringer Ingelheim, Chiesi, Cipla, GlaxoSmithKline plc, Kyorin, Meda, Merck & Co., Inc, Mundipharma, Novartis International AG, Pfizer, Inc., SkyePharma, Takeda, and Teva
    Patents/Royalties
    AKL Ltd. - Phytopharmaceuticals
    Grants
    • Agency: 
      UK National Health Service, British Lung Foundation
    • Agency: 
      Aerocrine
    • Agency: 
      AKL Ltd
    • Agency: 
      Almirall
    • Agency: 
      AstraZeneca plc
    • Agency: 
      Boehringer Ingelheim
    • Agency: 
      Chiesi
    • Agency: 
      Eli Lilly
    • Agency: 
      GlaxoSmithKline plc
    • Agency: 
      Meda
    • Agency: 
      Merck & Co. Inc
    • Agency: 
      Mundipharma
    • Agency: 
      Napp
    • Agency: 
      Novartis International AG
    • Agency: 
      Orion
    • Agency: 
      Pfizer Inc.
    • Agency: 
      Respiratory Effectiveness Group
    • Agency: 
      Takeda
    • Agency: 
      Teva
    • Agency: 
      Zentiva

Catherine C. Reed

  • Equity:
    Minor stockholder Eli Lilly and Company
    Sponsors:
    Employee at Eli Lilly and Company